| Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291) |
|---|
| 07/01/2010 | WO2010073126A2 Compounds useful in delivering anti-neoplastic therapy and diagnostic imaging to hypoxic cells and methods of use thereof |
| 07/01/2010 | WO2010072342A2 A method for the synthesis of a radionuclide-labeled compound |
| 07/01/2010 | US20100168554 Evaluating Cardiac Function With Dynamic Imaging Techniques and Contrast Media |
| 07/01/2010 | US20100168179 6-alkenyl-, 6-alkinyl- and 6-epoxy-epothilone derivatives, process for their production, and their use in pharmaceutical preparations |
| 07/01/2010 | US20100166656 Diagnostic And Radiotherapeutic Contrast Agents And Process For Their Preparation |
| 07/01/2010 | US20100166654 Single-Drug Multi-Ligand Conjugates for Targeted Drug Delivery |
| 07/01/2010 | US20100166653 Compositions of high specific activity sn-117m and methods of preparing the same |
| 07/01/2010 | US20100166652 Laminin receptor 1 precursor protein (37LRP) epitope delineated by an hepatocellular carcinoma specific antibody |
| 07/01/2010 | US20100166651 Radiotherapeutic High Specific Activity Tin-117m and Methods of Use |
| 07/01/2010 | US20100166650 Molecular imaging of living subjects using raman spectroscopy and labeled raman nanoparticles |
| 07/01/2010 | US20100166649 Method to inhibit cancer targeting cd24 |
| 07/01/2010 | CA2747575A1 A method for synthesis of a radionuclide-labeled compound using an exchange resin |
| 06/30/2010 | EP2201897A2 Tumor targeted photodiagnostic-phototherapeutic agents |
| 06/30/2010 | EP2200659A2 Use of lanthanide-based nanoparticles as radiosensitizing agents |
| 06/30/2010 | EP2200658A2 Positron emission tomography probes for imaging immune activation and selected cancers |
| 06/30/2010 | EP2200626A2 Analogues of exendin-4 and exendin-3 |
| 06/30/2010 | CN101765582A deuterium labelled ketamine |
| 06/30/2010 | CN101757644A Structure of radioactive micro balls and preparation method |
| 06/29/2010 | US7745577 cyclic peptide having amino acid sequences amidated or hydroxylated at the carboxy terminus and conjugated to a detectible agent and/or a cytotoxic agent, used for detecting tumors and preventing transformation of normal cells into tumor cells |
| 06/29/2010 | US7745114 Compositions and methods for identifying and targeting cancer cells of alimentary canal origin |
| 06/29/2010 | US7744910 Compounds and compositions for delivering active agents |
| 06/29/2010 | US7744870 A conjugated compound contains antibody or a Fab, and a radiostable therapeutic active agent; for diagnosis/therapy of colorectal cancer; biological conjugated drugs |
| 06/29/2010 | US7744853 Radiolabeled annexins |
| 06/29/2010 | US7744852 Device for marking a cavity in a breast for subsequent visualization including a delivery opening, first and second markers movable through opening, visualized by ultrasound and radiopacity; percutaneous minimally invasive large intact tissue sample collection; inserts; positioning; |
| 06/29/2010 | US7744851 Rreacting a hydrated 18F-radiolabeled fluoride ion source with an unsaturated carrier compound in a nucleophilic reaction to produce an 18F-radiolabeled carrier compound and reacting the 18F-radiolabeled carrier compound with a nucleophilic composition in a second nucleophilic reaction; tomography |
| 06/24/2010 | WO2010038044A3 Imaging techniques using a tridentate ligand |
| 06/24/2010 | WO2010037856A3 DYNACTIN-1/p150glued AS A TARGET FOR TUMOR DIAGNOSIS AND THERAPY AND A METHOD FOR IDENTIFYING TARGETABLE DISEASE-RELATED PROTEINS |
| 06/24/2010 | WO2009140743A3 Blood imaging |
| 06/24/2010 | US20100160211 Glycopeptide phosphonate derivatives |
| 06/24/2010 | US20100158803 Production and Use of Novel Peptide-Based Agents for Use with Bi-Specific Antibodies |
| 06/24/2010 | US20100158802 antibody binds target tissue and conjugate carrying epitope (haptens); monoclonal antibody or fragment thereof binds to a colon-specific antigen-p mucin (CSAp) antigen - the Mu-9 epitope; DNA sequence; colon cancer |
| 06/24/2010 | US20100158801 Methods for the treatment of acute myeloid leukemia |
| 06/24/2010 | US20100158800 Drug depot implant designs and methods of implantation |
| 06/24/2010 | US20100158799 Method and composition for bioactive agent release in vivo |
| 06/24/2010 | US20100158798 FP-Pocket-Binding Effectors and Methods for Using the Same to Modulate Telomerase Activity |
| 06/24/2010 | US20100158797 Use of a2a adenosine receptor agonists |
| 06/24/2010 | US20100158796 Amides of hyaluronic acid and the derivatives thereof and a process for their preparation |
| 06/24/2010 | US20100158795 Methods and systems for assessing lung function and delivering therapeutic agents |
| 06/24/2010 | DE102009029033A1 Tetrathiol-Liganden, Metallkomplexe, Konjugate und Kits, deren Verwendung in der nuklearmedizinischen Diagnostik und Endoradionuklidtherapie sowie Verfahren zur Herstellung der Tetrathiol-Liganden und Metallkomplexe Tetrathiol ligands, metal complexes, conjugates and kits, their use in diagnostic nuclear medicine and endoradionuclide therapy and methods of making the Tetrathiol ligands and metal complexes |
| 06/24/2010 | CA2747721A1 Tfpi inhibitors and methods of use |
| 06/23/2010 | EP2198040A1 In vivo imaging of myelin |
| 06/23/2010 | EP2197468A1 Pegylation by the dock and lock (dnl) technique |
| 06/23/2010 | CA2653163A1 Methods for the treatment of acute myeloid leukemia |
| 06/22/2010 | US7740882 polyoxyethylene glycol having multiple functional groups, at least one of which is covalently bound to a therapeutic or diagnostic agent (peptide) , and a cell uptake promoter (formyl-met-leu-phe)covalently bound to the therapeutic or diagnostic agent; conjugates; pharmacokinetic; bioavailability |
| 06/22/2010 | US7740854 Treatment of macrophage mediated disease |
| 06/22/2010 | US7740830 Imaging, diagnosis and treatment of disease |
| 06/22/2010 | CA2439062C Silicon implants comprising a radionuclide for use in brachytherapy |
| 06/22/2010 | CA2389553C Heteroaryl-diazabicycloalkanes |
| 06/22/2010 | CA2216963C Tie-2 ligands, methods of making and uses thereof |
| 06/17/2010 | WO2010066843A2 Biomolecule complexes as contrast agents in positron emission tomography (pet) based methods for the assessment of organ function |
| 06/17/2010 | WO2010066010A1 Process for the preparation of asymmetrical bis(thiosemicarbazones) |
| 06/17/2010 | US20100152233 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof |
| 06/17/2010 | US20100152232 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof |
| 06/17/2010 | US20100150836 Radiolabelled benzamide analogues, their synthesis and use in diagnostic imaging |
| 06/17/2010 | US20100150835 Synthesis of [18F] Fluoromethyl Benzene Using Benzyl Pentafluorobenzenesulfonate |
| 06/17/2010 | US20100150834 High affinity ephb receptor binding compounds and methods of use thereof |
| 06/17/2010 | US20100150833 Compounds and amyloid probes thereof for therapeutic and imaging uses |
| 06/17/2010 | US20100150832 Biodegradable polyketal polymers and methods for their formation and use |
| 06/17/2010 | US20100150831 Modulators of cxcr7 |
| 06/17/2010 | US20100150830 Method of treating cancer |
| 06/17/2010 | US20100150829 Antibodies to IL-6 and use thereof |
| 06/17/2010 | US20100150828 Radioactive gold nanoparticles and methods of making and using them |
| 06/17/2010 | US20100150827 Pyrido [2, 3-d] pyrimidin-7-one compounds as inhibitors of p13k-alpha for the treatment of cancer |
| 06/17/2010 | CA2746070A1 Process for the preparation of asymmetrical bis(thiosemicarbazones) |
| 06/16/2010 | EP2196222A1 Tricarbonyl complexes of rhenium and technetium comprising amino acids as bidentate ligands and their use as radiotherapeutic chemotoxic agents. |
| 06/16/2010 | EP2195335A1 Diagnostic agent |
| 06/16/2010 | EP2195037A2 Radiofluorination methods |
| 06/16/2010 | EP2195036A1 Compositions for treatment of tumors by direct administration of a radioisotope |
| 06/16/2010 | CN1981029B Cholesterol-producing yeast strains and uses thereof |
| 06/16/2010 | CN1913926B Method and kit for the production of particles labelled with rhenium-188 |
| 06/16/2010 | CN101743256A an anti-cancer cytotoxic monoclonal antibody |
| 06/16/2010 | CN101743255A an anti-cancer cytotoxic monoclonal antibody |
| 06/16/2010 | CN101732736A Medicine box for preparing technetium-99m labeled DTPA-LSA, preparation method and application thereof |
| 06/15/2010 | US7737255 monoclonal antibodies used for analyzing changes in the levels of cancer specific genes in cells, tissues or bodily fluids; medical prognosis |
| 06/15/2010 | US7736647 an antigen binding fragment comprising a heavy chain and a light chain variable region amino acid sequences, associated to effector cells for triggering antibody-dependent cell-mediated cytotoxicity (ADCC) mechanisms; useful for inhibiting proliferation and/or killing melanoma cells |
| 06/15/2010 | US7736622 Methods of diagnosing small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions |
| 06/15/2010 | CA2250080C Humanization of an anti-carcinoembryonic antigen anti-idiotype antibody and use as a tumor vaccine and for targeting applications |
| 06/10/2010 | WO2010065954A2 Sparc binding peptides and uses thereof |
| 06/10/2010 | WO2010065950A2 Albumin binding peptide-mediated disease targeting |
| 06/10/2010 | WO2010065906A2 Ca-ix specific radiopharmaceuticals for the treatment and imaging of cancer |
| 06/10/2010 | WO2010065902A2 Technetium- and rhenium-bis(heteroaryl) complexes and methods of use thereof for inhibiting psma |
| 06/10/2010 | WO2010065899A2 Technetium-and rhenium-bis(heteroaryl)complexes and methods of use thereof |
| 06/10/2010 | WO2010065572A1 Sstr1-selective analogs |
| 06/10/2010 | WO2010065079A2 Antibodies to il-6 and use thereof |
| 06/10/2010 | WO2010065077A2 Antagonists of il-6 to prevent or treat thrombosis |
| 06/10/2010 | WO2010063701A2 In vivo imaging method |
| 06/10/2010 | WO2010063069A1 Nitrogen-containing macrocyclic conjugates as radiopharmaceuticals |
| 06/10/2010 | US20100146650 Method for generating active antibodies against a resistance antigen, antibodies obtained by said method and their uses |
| 06/10/2010 | US20100144637 Nucleic acid and corresponding protein entitled 161p5c5 useful in treatment and detection of cancer |
| 06/10/2010 | US20100143253 Compounds and amyloid probes thereof for therapeutic and imaging uses |
| 06/10/2010 | US20100143252 Imaging 18f or 11c-labelled alkylthiophenyl guanidines |
| 06/10/2010 | US20100143251 Compounds and amyloid probes thereof for therapeutic and imaging uses |
| 06/10/2010 | US20100143250 Compounds for the diagnosis of apoptosis |
| 06/10/2010 | US20100143249 Folate-conjugates and corresponding metal-chelate complexes for use in diagnostic imaging and radiotherapy |
| 06/10/2010 | US20100143248 Methods for diagnosing and monitoring treatment of adhd by assessing the dopamine transporter level |
| 06/10/2010 | US20100143247 Diagnosis of prostate cancer |
| 06/10/2010 | US20100143246 Interleukin 17 Receptor-Like Protein |
| 06/10/2010 | US20100143245 Uses of monoclonal antibody 8h9 |
| 06/10/2010 | US20100143244 Monoclonal antibodies to human thymidine kinase to treat cancer |
| 06/10/2010 | US20100143243 Frozen compositions and methods for piercing a substrate |